Stock listing
BOATS:HALO Halozyme Therapeutics, Inc. Stock
US listing (BOATS) of Halozyme Therapeutics, Inc. · home listing NASDAQ:HALO
Follow Halozyme Therapeutics, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:HALO
$122.96 USD -7.38 (-5.7%)
Close on Nov 5, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:HALO
- Day range
- $122.77 – $131.44 USDNov 5, 2026
- Volume
- 2.86M sharesNov 5, 2026
- Market cap
- $13.96B USDAt the close on Nov 5, 2026 · price × 113.5M shares outstanding
- 52-week range
- $61.23 – $133.96 USDLowest and highest trades, Nov 6, 2025 – Nov 5, 2026
- Traded on an average day
- $258.5M USDMedian day 1.88M shares · last 3 months, Aug 5, 2026 – Nov 5, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:HALO · Home | $122.96 USD | -7.38 (-5.7%) | 2,863,794 | $130.64 | $131.44 | $122.77 | $130.34 | Close on Nov 5, 2026 |
| Frankfurt:RV7 | €114.15 EUR | -3.85 (-3.3%) | — | €114.95 | €115.00 | €114.15 | €118.00 | Close on Nov 5, 2026 |
| LSE:0J2O | $124.93 USD | -3.533 (-2.7%) | 2,336 | $128.73 | $132.16 | $124.22 | $128.46 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 5, 2026 – Nov 5, 2026 · NASDAQ:HALO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $122.96 | -7.38 | -5.7% | $130.64 | $131.44 | $122.77 | 2,863,794 | |
| $130.34 | +1.72 | +1.3% | $130.81 | $130.98 | $126.86 | 1,589,126 | |
| $128.62 | -0.33 | -0.3% | $128.29 | $131.36 | $128.26 | 1,412,955 | |
| $128.95 | -1.96 | -1.5% | $130.52 | $131.89 | $127.52 | 3,364,009 | |
| $130.91 | -0.27 | -0.2% | $132.66 | $133.96 | $130.31 | 1,402,092 | |
| $131.18 | +1.15 | +0.9% | $131.02 | $132.55 | $130.09 | 1,874,508 | |
| $130.03 | +1.53 | +1.2% | $126.78 | $130.23 | $126.25 | 1,337,163 | |
| $128.50 | +0.49 | +0.4% | $127.21 | $128.65 | $126.13 | 1,698,709 | |
| $128.01 | +2.38 | +1.9% | $126.86 | $128.11 | $126.03 | 1,237,100 | |
| $125.63 | +1.09 | +0.9% | $124.54 | $126.23 | $123.74 | 1,528,614 | |
| $124.54 | -0.29 | -0.2% | $124.72 | $124.91 | $121.62 | 5,097,794 | |
| $124.83 | +0.46 | +0.4% | $123.90 | $125.43 | $122.71 | 1,715,808 | |
| $124.37 | +1.87 | +1.5% | $123.54 | $125.10 | $123.00 | 2,149,245 | |
| $122.50 | +0.66 | +0.5% | $121.72 | $123.60 | $121.69 | 1,894,415 | |
| $121.84 | +0.33 | +0.3% | $122.19 | $122.45 | $120.19 | 2,082,300 | |
| $121.51 | +4.69 | +4.0% | $118.35 | $122.33 | $117.38 | 2,470,000 | |
| $116.82 | +7.20 | +6.6% | $109.90 | $119.21 | $109.42 | 3,769,000 | |
| $109.62 | -1.46 | -1.3% | $111.92 | $111.92 | $108.80 | 1,772,700 | |
| $111.08 | +0.66 | +0.6% | $110.19 | $112.43 | $109.96 | 1,660,300 | |
| $110.42 | +0.58 | +0.5% | $109.70 | $112.65 | $109.70 | 1,845,300 | |
| $109.84 | -0.95 | -0.9% | $109.41 | $110.64 | $107.41 | 2,490,300 | |
| $110.79 | +1.07 | +1.0% | $111.62 | $114.00 | $110.16 | 2,179,300 | |
| $109.72 | +1.41 | +1.3% | $108.87 | $111.25 | $107.43 | 1,774,300 | |
| $108.31 | -1.55 | -1.4% | $109.62 | $109.87 | $107.68 | 1,855,900 | |
| $109.86 | +2.92 | +2.7% | $106.96 | $109.99 | $106.65 | 2,599,800 | |
| $106.94 | -3.46 | -3.1% | $109.93 | $110.50 | $106.84 | 2,329,000 | |
| $110.40 | -1.16 | -1.0% | $111.54 | $112.45 | $110.35 | 3,521,100 | |
| $111.56 | -1.33 | -1.2% | $112.89 | $114.52 | $111.03 | 2,872,900 | |
| $112.89 | -1.01 | -0.9% | $113.34 | $113.94 | $112.10 | 2,236,700 | |
| $113.90 | -1.32 | -1.1% | $115.36 | $115.63 | $113.43 | 1,958,300 | |
| $115.22 | +2.78 | +2.5% | $112.13 | $116.09 | $111.07 | 3,171,600 | |
| $112.44 | -2.69 | -2.3% | $116.85 | $116.85 | $112.18 | 2,702,800 | |
| $115.13 | +3.68 | +3.3% | $111.50 | $115.18 | $110.95 | 4,150,400 | |
| $111.45 | -1.00 | -0.9% | $112.80 | $113.47 | $111.05 | 2,876,800 | |
| $112.45 | +2.77 | +2.5% | $109.72 | $112.66 | $109.38 | 10,183,400 | |
| $109.68 | +1.24 | +1.1% | $107.08 | $110.88 | $106.82 | 1,983,600 | |
| $108.44 | +2.19 | +2.1% | $106.66 | $109.63 | $105.50 | 1,709,900 | |
| $106.25 | -1.69 | -1.6% | $108.14 | $108.14 | $106.14 | 1,055,600 | |
| $107.94 | +0.74 | +0.7% | $108.00 | $108.61 | $106.65 | 912,500 | |
| $107.20 | +0.20 | +0.2% | $107.96 | $108.23 | $106.34 | 861,500 | |
| $107.00 | -0.39 | -0.4% | $106.93 | $107.95 | $106.36 | 1,464,400 | |
| $107.39 | -0.92 | -0.8% | $107.67 | $108.79 | $106.62 | 1,746,300 | |
| $108.31 | -1.88 | -1.7% | $109.00 | $109.96 | $106.07 | 1,625,600 | |
| $110.19 | -0.57 | -0.5% | $109.91 | $111.15 | $109.00 | 1,010,600 | |
| $110.76 | +1.10 | +1.0% | $109.84 | $111.15 | $108.74 | 1,889,600 | |
| $109.66 | +1.94 | +1.8% | $105.84 | $109.76 | $105.48 | 1,619,200 | |
| $107.72 | +1.23 | +1.2% | $107.45 | $108.53 | $106.87 | 1,058,600 | |
| $106.49 | +1.14 | +1.1% | $104.48 | $106.94 | $103.47 | 1,280,000 | |
| $105.35 | -1.57 | -1.5% | $106.45 | $106.81 | $104.70 | 1,681,800 | |
| $106.92 | -0.14 | -0.1% | $106.87 | $107.55 | $106.05 | 1,364,600 | |
| $107.06 | -2.26 | -2.1% | $109.32 | $109.66 | $107.00 | 1,705,800 | |
| $109.32 | +0.68 | +0.6% | $109.33 | $109.55 | $107.55 | 1,598,158 | |
| $108.64 | +0.47 | +0.4% | $108.00 | $109.10 | $106.87 | 2,091,282 | |
| $108.17 | +2.05 | +1.9% | $106.20 | $108.49 | $105.91 | 1,150,300 | |
| $106.12 | -1.50 | -1.4% | $106.41 | $107.44 | $105.20 | 1,577,500 | |
| $107.62 | +2.73 | +2.6% | $106.39 | $107.96 | $105.50 | 2,539,100 | |
| $104.89 | +1.89 | +1.8% | $102.95 | $105.11 | $102.39 | 1,955,300 | |
| $103.00 | +4.34 | +4.4% | $98.86 | $104.09 | $98.58 | 2,199,600 | |
| $98.66 | -2.01 | -2.0% | $100.35 | $100.83 | $98.13 | 1,658,900 | |
| $100.67 | -1.12 | -1.1% | $101.95 | $102.40 | $99.41 | 1,982,800 | |
| $101.79 | -0.83 | -0.8% | $102.00 | $102.58 | $100.47 | 3,650,500 | |
| $102.62 | 0.00 | 0.0% | $103.62 | $104.78 | $101.81 | 2,846,000 | |
| $102.62 | -0.50 | -0.5% | $102.67 | $104.77 | $101.11 | 4,935,000 | |
| $103.12 | +17.36 | +20.2% | $90.00 | $103.30 | $90.00 | 7,691,600 | |
| $85.76 | +2.17 | +2.6% | $84.15 | $86.00 | $82.60 | 2,704,000 | |
| $83.59 | +0.36 | +0.4% | $83.89 | $84.40 | $82.98 | 1,262,600 |
- Ticker
- BOATS:HALO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 6, 2026
Halozyme Reaffirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Medicare Drug Price Negotiation Program Final Rule for IPAY 2029
Latest earnings call · Nov 5, 2026
Halozyme Therapeutics (NASDAQ:HALO) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q3 2026 Earnings Presentation
Earnings · 14 slides
Calls
Replays
Halozyme Therapeutics (NASDAQ:HALO) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 4:30 PM ET
Watch TranscriptHalozyme Therapeutics (NASDAQ:HALO) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 4:30 PM ET
Watch TranscriptHalozyme Therapeutics (NASDAQ:HALO) Q1 2026 Earnings Call
Mon, May 11, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Halozyme to Report Third Quarter 2026 Financial and Operating Results
Oct 22, 2026
Closed $124.54 (-0.2%) on Oct 22, 2026
Halozyme Wins Injunction Stopping Manufacture and Sale of Merck's Keytruda SC in Multiple European Markets
Oct 7, 2026
Closed $110.79 (+1.0%) on Oct 7, 2026
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology
Oct 6, 2026
Closed $110.79 (+1.0%) on Oct 7, 2026
Halozyme Announces Appointment of Jim Daly to its Board of Directors
Sep 30, 2026
Closed $106.94 (-3.1%) on Oct 1, 2026
Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033
Sep 17, 2026
Closed $112.45 (+2.5%) on Sep 18, 2026
Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes due 2033
Sep 16, 2026
Closed $109.68 (+1.1%) on Sep 17, 2026
Halozyme Appoints Dannielle Appelhans to its Board of Directors
Aug 18, 2026
Closed $107.62 (+2.6%) on Aug 19, 2026
Financings
1.50% convertible senior notes due 2033
Sep 18, 2026
Made bigger: US$1.3B
Use of proceeds: About $162.5 million to fund the cost of capped call transactions
0% convertible senior notes due 2031
Nov 6, 2025
Update: US$650M
Use of proceeds: Fund capped call transactions, repurchase existing 2027 and 2028 convertible notes, and general corporate purposes
0.875% convertible senior notes due 2032
Nov 6, 2025
Update: US$650M
Use of proceeds: Fund capped call transactions, repurchase existing 2027 and 2028 convertible notes, and general corporate purposes
Decks
Q3 2026 Earnings Presentation
Earnings · 14 slides · Nov 5, 2026
Q2 2026 Earnings Presentation
Earnings · 15 slides · Aug 6, 2026
Q1 2026 Earnings Presentation
Earnings · 17 slides · May 11, 2026
FY2025 Earnings Presentation
Earnings · 18 slides · Feb 17, 2026
Halozyme Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 42 in the last 12 months · 223 in all · newest Nov 6, 2026 · oldest 2019
- Calls
- 27 calls with a replay · 27 with a transcript · latest Nov 5, 2026
- Decks
- 63 decks · latest Nov 5, 2026
Where Halozyme Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:HALO · Home listing | NASDAQ | United States | USD |
| gettex:RV7 | gettex | Germany | EUR |
| Tradegate:RV7 | Tradegate | Germany | EUR |
| LS Exchange:A0DLHS | LS Exchange | Germany | EUR |
| BOATS:HALO · This page | BOATS | United States | USD |
| Frankfurt:RV7 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A0DLHS | Lang & Schwarz | Germany | EUR |
| BMV:HALO | BMV | Mexico | MXN |
| LSE:0J2O | LSE | United Kingdom | USD |
| Milan:1HALO | Milan | Italy | EUR |
| BIVA:HALO | BIVA | Mexico | MXN |
| BX Swiss:RV7 | BX Swiss | Switzerland | CHF |
| Dusseldorf:RV7 | Dusseldorf | Germany | EUR |
| Hamburg:RV7 | Hamburg | Germany | EUR |
| Munich:RV7 | Munich | Germany | EUR |
| Stuttgart:RV7 | Stuttgart | Germany | EUR |
| Hanover:RV7 | Hanover | Germany | EUR |
| Xetra:RV7 | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Halozyme Therapeutics, Inc.